Low
₹383.00
High
₹395.95
| Previous Close | ₹385.80 |
|---|---|
| Day's Range | ₹383.00 - ₹395.95 |
| Open | ₹390.00 |
| 52 Week Range | ₹278.20 - ₹668.00 |
| Volume | 15,556 |
| Market Cap | ₹0.00 |
| Trade Value ( ₹ in Lacs) | 60.25 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 9.19 |
| TTM EPS (₹) | 41.89 |
| P/E Ratio | 35.47 |
| Book Value(₹) | 1.00 |
| PAT Margin (%) | 6.51 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 6.34 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 4478.3 | 14421.6 |
| Expenses | N/A | N/A |
| PBT | 618.0 | -921.8 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 468.9 | -921.8 |
| Founded | 1962 |
|---|---|
| Managing Director | Pabitrakumar Kalipada Bhattacharyya |
| NSE Symbol | UNICHEMLAB |
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,43,229.15 | 1,847.30 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,78,100.22 | 6,708.90 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,48,250.95 | 4,376.45 | 3,101.60 - 3,101.60 |
| Apollo Hospitals Enterprise Ltd. | 1,16,391.52 | 8,094.85 | 6,677.50 - 6,677.50 |
| Cipla Ltd. | 1,08,864.87 | 1,347.70 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,08,721.36 | 2,377.90 | 1,836.80 - 1,836.80 |
| Dr. Reddy's Laboratories Ltd. | 1,07,942.01 | 1,293.00 | 1,138.50 - 1,138.50 |
| Mankind Pharma Ltd. | 1,00,199.63 | 2,427.15 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 98,526.33 | 1,012.45 | 903.00 - 903.00 |
| Zydus Lifesciences Ltd. | 94,475.31 | 938.00 | 835.50 - 835.50 |
No Records Found
Unichem Laboratories has informed that it enclosed the Postal Ballot Notice (‘Notice’) together with the explanatory statement seeking the approval of the members of the Company on the following Special Business items as set out in the Notice dated 5th February 2026: 1. Special resolution for approval of appointment of Dr. (Ms) Swati Patankar (DIN 06594600) as a Non-Executive Independent Director for a term of five years with effect from 5th February 2026. 2. Ordinary resolution for approval of material related party transaction(s) between Ipca Laboratories (‘Ipca’), holding company of Unichem Laboratories (‘Unichem’) and Unichem Pharmaceuticals USA Inc. (‘Unichem USA’), wholly owned subsidiary of Unichem. 3. Ordinary resolution for approval of material related party transaction(s) with Unichem USA, wholly owned subsidiary of Unichem. Notice is being sent through electronic mode to those members whose e-mail addresses are registered with the Company/Depositories and whose names are recorded in the Register of Members of the Company or in the Register of Beneficial Owners maintained by the Depositories as on Friday, 20th February 2026. The notice is being sent by e-mail on 25th February 2026 to the members who have registered their e-mail IDs with Depository Participant(s) or with the Company. E-voting period will commence from Thursday, 26th February 2026, IST at 9.00 am and will end on Friday, 27th March 2026 IST at 5.00 pm. The Notice will also be available on the website of the Company at www.unichemlabs.com and on the website of the National Securities Depository (NSDL) at https://www.evoting.nsdl.com.
The above information is a part of company’s filings submitted to BSE.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 1164.10 | 872.06 | 33.49 | 4527.66 | 3514.11 | 28.84 | 4527.66 | 3514.11 | 28.84 |
| Other Income | 51.63 | 45.30 | 13.97 | 633.88 | 614.90 | 3.09 | 633.88 | 614.90 | 3.09 |
| PBIDT | 320.18 | 187.00 | 71.22 | 1738.22 | 1321.69 | 31.51 | 1738.22 | 1321.69 | 31.51 |
| Interest | 0.60 | 0.77 | -22.08 | 2.07 | 2.36 | -12.29 | 2.07 | 2.36 | -12.29 |
| PBDT | 319.58 | 186.23 | 71.61 | 1697.57 | 1319.33 | 28.67 | 1697.57 | 1319.33 | 28.67 |
| Depreciation | 31.15 | 31.14 | 0.03 | 120.83 | 114.05 | 5.94 | 120.83 | 114.05 | 5.94 |
| PBT | 288.43 | 155.09 | 85.98 | 1576.74 | 1205.28 | 30.82 | 1576.74 | 1205.28 | 30.82 |
| TAX | 65.48 | 44.55 | 46.98 | 258.68 | 181.08 | 42.85 | 258.68 | 181.08 | 42.85 |
| Deferred Tax | -2.22 | 9.10 | -124.40 | -12.01 | 12.22 | -198.28 | -12.01 | 12.22 | -198.28 |
| PAT | 222.95 | 110.54 | 101.69 | 1318.06 | 1024.20 | 28.69 | 1318.06 | 1024.20 | 28.69 |
| Equity | 223.85 | 223.76 | 0.04 | 223.85 | 223.76 | 0.04 | 223.85 | 223.76 | 0.04 |
| PBIDTM(%) | 27.50 | 21.44 | 28.26 | 38.39 | 37.61 | 2.07 | 38.39 | 37.61 | 2.07 |
No Records Found
The current share price of Unichem Laboratories Ltd. is ₹385.80 as of 2026-05-08.
The market capitalisation of Unichem Laboratories Ltd. is ₹2,711.33 as of 2026-05-08.
The 1-year return of Unichem Laboratories Ltd. is 0.00% as of 2026-05-08.
The P/E ratio of Unichem Laboratories Ltd. is 35.47 as of 2026-05-10.
The 52-week high and low of Unichem Laboratories Ltd. are ₹668.00 and ₹278.20, respectively, as of 2026-05-08.
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.